2017 Q4 Form 10-Q Financial Statement
#000117992917000221 Filed on November 07, 2017
Income Statement
| Concept | 2017 Q4 | 2017 Q3 | 2016 Q3 |
|---|---|---|---|
| Revenue | $4.949B | $5.031B | $4.546B |
| YoY Change | 9.15% | 10.67% | 25.89% |
| Cost Of Revenue | $4.374B | $4.343B | $3.867B |
| YoY Change | 10.26% | 12.31% | 26.79% |
| Gross Profit | $446.0M | $564.0M | $471.0M |
| YoY Change | 25.99% | 19.75% | 25.94% |
| Gross Profit Margin | 9.01% | 11.21% | 10.36% |
| Selling, General & Admin | $474.0M | $489.0M | $525.0M |
| YoY Change | -11.57% | -6.86% | 24.2% |
| % of Gross Profit | 106.28% | 86.7% | 111.46% |
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $39.00M | $43.00M | $46.00M |
| YoY Change | -17.02% | -6.52% | 50.82% |
| % of Gross Profit | 8.74% | 7.62% | 9.77% |
| Operating Expenses | $502.0M | $522.0M | $561.0M |
| YoY Change | -12.39% | -6.95% | 25.06% |
| Operating Profit | -$56.00M | -$81.00M | $118.0M |
| YoY Change | 833.33% | -168.64% | 4.42% |
| Interest Expense | -$33.00M | $32.00M | $26.00M |
| YoY Change | 32.0% | 23.08% | 73.33% |
| % of Operating Profit | 22.03% | ||
| Other Income/Expense, Net | -$14.00M | -$32.00M | -$26.00M |
| YoY Change | 23.08% | -273.33% | |
| Pretax Income | -$316.0M | -$113.0M | $92.00M |
| YoY Change | 919.35% | -222.83% | -6.12% |
| Income Tax | -$108.0M | -$16.00M | $50.00M |
| % Of Pretax Income | 54.35% | ||
| Net Earnings | -$262.0M | -$97.00M | $42.00M |
| YoY Change | 457.45% | -330.95% | -8.7% |
| Net Earnings / Revenue | -5.29% | -1.93% | 0.92% |
| Basic Earnings Per Share | -$4.59 | -$1.70 | $0.77 |
| Diluted Earnings Per Share | -$4.59 | -$1.70 | $0.76 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 57.09M shares | 56.50M shares | 56.00M shares |
| Diluted Shares Outstanding | 56.50M shares | 56.00M shares |
Balance Sheet
| Concept | 2017 Q4 | 2017 Q3 | 2016 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $5.710B | $5.721B | $4.577B |
| YoY Change | 24.75% | 24.99% | 26.24% |
| Cash & Equivalents | $3.186B | $3.934B | $2.842B |
| Short-Term Investments | $2.524B | $1.787B | $1.735B |
| Other Short-Term Assets | $876.0M | $925.0M | $483.0M |
| YoY Change | 120.1% | 91.51% | 301.04% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $871.0M | $1.002B | $1.053B |
| Other Receivables | $54.00M | $60.00M | $0.00 |
| Total Short-Term Assets | $7.511B | $7.708B | $6.113B |
| YoY Change | 25.43% | 26.09% | 24.49% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $342.0M | $397.0M | $450.0M |
| YoY Change | -24.67% | -11.78% | 20.04% |
| Goodwill | $186.0M | $430.0M | $619.0M |
| YoY Change | -70.0% | -30.53% | 92.7% |
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $141.0M | $42.00M | $40.00M |
| YoY Change | 243.9% | 5.0% | 9.25% |
| Total Long-Term Assets | $960.0M | $1.246B | $1.457B |
| YoY Change | -34.29% | -14.48% | 45.02% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $7.511B | $7.708B | $6.113B |
| Total Long-Term Assets | $960.0M | $1.246B | $1.457B |
| Total Assets | $8.471B | $8.954B | $7.570B |
| YoY Change | 13.72% | 18.28% | 27.98% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $366.0M | $485.0M | $383.0M |
| YoY Change | -4.94% | 26.63% | 39.73% |
| Accrued Expenses | |||
| YoY Change | |||
| Deferred Revenue | $282.0M | ||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $653.0M | $782.0M | $466.0M |
| YoY Change | 38.35% | 67.81% | 3.38% |
| Total Short-Term Liabilities | $5.557B | $5.962B | $4.665B |
| YoY Change | 21.6% | 27.8% | 20.82% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $1.318B | $1.317B | $1.169B |
| YoY Change | 35.18% | 12.66% | 145.33% |
| Other Long-Term Liabilities | $61.00M | $48.00M | $39.00M |
| YoY Change | 45.24% | 23.08% | 20.86% |
| Total Long-Term Liabilities | $1.379B | $1.365B | $1.208B |
| YoY Change | 35.59% | 13.0% | 3643.41% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $5.557B | $5.962B | $4.665B |
| Total Long-Term Liabilities | $1.379B | $1.365B | $1.208B |
| Total Liabilities | $7.134B | $7.525B | $5.879B |
| YoY Change | 23.0% | 28.0% | 33.7% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $298.0M | $560.0M | $857.0M |
| YoY Change | -63.21% | -34.66% | 17.6% |
| Common Stock | $1.044B | $870.0M | $831.0M |
| YoY Change | 24.14% | 4.69% | 5.2% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $1.337B | $1.429B | $1.691B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $8.471B | $8.954B | $7.570B |
| YoY Change | 13.72% | 18.28% | 27.98% |
Cashflow Statement
| Concept | 2017 Q4 | 2017 Q3 | 2016 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$262.0M | -$97.00M | $42.00M |
| YoY Change | 457.45% | -330.95% | -8.7% |
| Depreciation, Depletion And Amortization | $39.00M | $43.00M | $46.00M |
| YoY Change | -17.02% | -6.52% | 50.82% |
| Cash From Operating Activities | -$153.0M | $285.0M | $355.0M |
| YoY Change | -482.5% | -19.72% | 37.54% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$1.000M | -$25.00M | -$41.00M |
| YoY Change | -96.97% | -39.02% | 18.84% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$587.0M | $396.0M | $183.0M |
| YoY Change | 1297.62% | 116.39% | -348.3% |
| Cash From Investing Activities | -$588.0M | $371.0M | $142.0M |
| YoY Change | 684.0% | 161.27% | -231.12% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 4.000M | 299.0M | 0.000 |
| YoY Change | -50.0% | -100.0% | |
| NET CHANGE | |||
| Cash From Operating Activities | -153.0M | 285.0M | 355.0M |
| Cash From Investing Activities | -588.0M | 371.0M | 142.0M |
| Cash From Financing Activities | 4.000M | 299.0M | 0.000 |
| Net Change In Cash | -737.0M | 955.0M | 497.0M |
| YoY Change | 2629.63% | 92.15% | 230.89% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$153.0M | $285.0M | $355.0M |
| Capital Expenditures | -$1.000M | -$25.00M | -$41.00M |
| Free Cash Flow | -$152.0M | $310.0M | $396.0M |
| YoY Change | -308.22% | -21.72% | 35.34% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
0 | USD | |
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2017 | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-09-30 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001179929 | ||
| CY2017Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
57094000 | shares |
| dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
MOLINA HEALTHCARE INC | ||
| dei |
Trading Symbol
TradingSymbol
|
moh | ||
| CY2016Q4 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
|
-1000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
|
-27000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayableCurrentYear
|
-27000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayablePriorYears
|
0 | USD |
| CY2016Q4 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
|
55000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
|
10000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayableCurrentYear
|
0 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayablePriorYears
|
10000000 | USD |
| CY2016Q4 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
|
-522000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
|
-655000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear
|
-655000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayablePriorYears
|
0 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Current Year
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedCurrentYear
|
76000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Not Recognized Prior Years
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivableNotRecognizedPriorYears
|
52000000 | USD |
| CY2016Q4 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
|
-1000000 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
|
0 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayableCurrentYear
|
0 | USD |
| CY2017Q3 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayablePriorYears
|
0 | USD |
| moh |
Amortization Of Debt Discount Premium And Sale Leaseback Financing Obligation
AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation
|
23000000 | USD | |
| moh |
Amortization Of Debt Discount Premium And Sale Leaseback Financing Obligation
AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation
|
24000000 | USD | |
| CY2016Q3 | moh |
Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
|
26000000 | USD |
| moh |
Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
|
80000000 | USD | |
| CY2017Q3 | moh |
Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
|
24000000 | USD |
| moh |
Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
|
72000000 | USD | |
| CY2016Q3 | moh |
Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
|
0 | USD |
| moh |
Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
|
54000000 | USD | |
| CY2017Q3 | moh |
Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
|
3000000 | USD |
| moh |
Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
|
9000000 | USD | |
| moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
102000000 | USD | |
| moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
0 | USD | |
| moh |
Business Combination Purchase Price Amounts Accrued Received
BusinessCombinationPurchasePriceAmountsAccruedReceived
|
8000000 | USD | |
| moh |
Business Combination Purchase Price Amounts Accrued Received
BusinessCombinationPurchasePriceAmountsAccruedReceived
|
0 | USD | |
| CY2016Q4 | moh |
Capitation Claims Payable
CapitationClaimsPayable
|
37000000 | USD |
| CY2017Q3 | moh |
Capitation Claims Payable
CapitationClaimsPayable
|
57000000 | USD |
| moh |
Changes In Amounts Due To And Due From Affiliates
ChangesInAmountsDueToAndDueFromAffiliates
|
0 | USD | |
| moh |
Changes In Amounts Due To And Due From Affiliates
ChangesInAmountsDueToAndDueFromAffiliates
|
0 | USD | |
| CY2017Q3 | moh |
Class Of Warrant Or Right Stated Percentage
ClassOfWarrantOrRightStatedPercentage
|
0.01125 | |
| CY2016Q3 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
55000000 | USD |
| moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
163000000 | USD | |
| CY2017Q3 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
0 | USD |
| moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
0 | USD | |
| CY2016Q3 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
85000000 | USD |
| moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
251000000 | USD | |
| CY2017Q3 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
0 | USD |
| moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
0 | USD | |
| CY2016Q3 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
127000000 | USD |
| moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
345000000 | USD | |
| CY2017Q3 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
106000000 | USD |
| moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
331000000 | USD | |
| CY2016Q4 | moh |
Health Care Reform Premium Deficiency Reserve
HealthCareReformPremiumDeficiencyReserve
|
30000000 | USD |
| CY2017Q2 | moh |
Health Care Reform Premium Deficiency Reserve
HealthCareReformPremiumDeficiencyReserve
|
100000000 | USD |
| CY2017Q3 | moh |
Health Care Reform Premium Deficiency Reserve
HealthCareReformPremiumDeficiencyReserve
|
70000000 | USD |
| CY2017Q3 | moh |
Health Care Reform Premium Deficiency Reserve Projected Impact From Changein Computation
HealthCareReformPremiumDeficiencyReserveProjectedImpactFromChangeinComputation
|
125000000 | USD |
| moh |
Health Care Reform Premium Deficiency Reserve Projected Increase
HealthCareReformPremiumDeficiencyReserveProjectedIncrease
|
55000000 | USD | |
| moh |
Increase Decrease In Medical Premium Liability Due To Agency
IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
|
503000000 | USD | |
| moh |
Increase Decrease In Medical Premium Liability Due To Agency
IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
|
122000000 | USD | |
| CY2016Q3 | moh |
Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
|
33000000 | USD |
| moh |
Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
|
114000000 | USD | |
| CY2017Q3 | moh |
Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
|
36000000 | USD |
| moh |
Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
|
113000000 | USD | |
| CY2016Q4 | moh |
Medical Claims And Benefits Payable
MedicalClaimsAndBenefitsPayable
|
225000000 | USD |
| CY2017Q3 | moh |
Medical Claims And Benefits Payable
MedicalClaimsAndBenefitsPayable
|
403000000 | USD |
| moh |
Medical Claims And Benefits Payable Adjustments Change In Provider
MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
|
70000000 | USD | |
| moh |
Medical Claims And Benefits Payable Adjustments Change In Provider
MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
|
172000000 | USD | |
| CY2016Q4 | moh |
Medical Premium Liability Due To Agency
MedicalPremiumLiabilityDueToAgency
|
1202000000 | USD |
| CY2017Q3 | moh |
Medical Premium Liability Due To Agency
MedicalPremiumLiabilityDueToAgency
|
1324000000 | USD |
| CY2016Q3 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
42000000 | USD |
| moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
99000000 | USD | |
| CY2016Q3 | moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.006 | |
| moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.011 | ||
| CY2017Q3 | moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.006 | |
| moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.006 | ||
| CY2016Q3 | moh |
Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
|
26000000 | USD |
| moh |
Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
|
134000000 | USD | |
| CY2017Q3 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
-97000000 | USD |
| moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
-250000000 | USD | |
| moh |
Noncash Restructuring Charges
NoncashRestructuringCharges
|
0 | USD | |
| moh |
Noncash Restructuring Charges
NoncashRestructuringCharges
|
49000000 | USD | |
| CY2016Q4 | moh |
Other Claims Payable
OtherClaimsPayable
|
428000000 | USD |
| CY2017Q3 | moh |
Other Claims Payable
OtherClaimsPayable
|
615000000 | USD |
| CY2016Q4 | moh |
Pharmacy Claims Payable
PharmacyClaimsPayable
|
112000000 | USD |
| CY2017Q3 | moh |
Pharmacy Claims Payable
PharmacyClaimsPayable
|
125000000 | USD |
| moh |
Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
|
0.113 | ||
| moh |
Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
|
-0.005 | ||
| moh |
Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
|
0.013 | ||
| moh |
Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
|
-0.001 | ||
| moh |
Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
|
0.012 | ||
| moh |
Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
|
0.000 | ||
| CY2016Q3 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
127000000 | USD |
| moh |
Premium Tax Expenses
PremiumTaxExpenses
|
345000000 | USD | |
| CY2017Q3 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
106000000 | USD |
| moh |
Premium Tax Expenses
PremiumTaxExpenses
|
331000000 | USD | |
| CY2017Q3 | moh |
Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
|
27000000 | USD |
| moh |
Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
|
81000000 | USD | |
| moh |
Unrecognized Compensation Forfeited Rate
UnrecognizedCompensationForfeitedRate
|
0.045 | ||
| CY2016Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
385000000 | USD |
| CY2017Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
485000000 | USD |
| CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-2000000 | USD |
| CY2017Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1000000 | USD |
| CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
841000000 | USD |
| CY2017Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
870000000 | USD |
| CY2016Q3 | us-gaap |
Administrative Services Revenue
AdministrativeServicesRevenue
|
13000000 | USD |
| us-gaap |
Administrative Services Revenue
AdministrativeServicesRevenue
|
40000000 | USD | |
| CY2017Q3 | us-gaap |
Administrative Services Revenue
AdministrativeServicesRevenue
|
12000000 | USD |
| us-gaap |
Administrative Services Revenue
AdministrativeServicesRevenue
|
38000000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
24000000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
38000000 | USD | |
| CY2016Q4 | us-gaap |
Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
|
1492000000 | USD |
| CY2017Q3 | us-gaap |
Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
|
1696000000 | USD |
| CY2016Q4 | us-gaap |
Assets
Assets
|
7449000000 | USD |
| CY2017Q3 | us-gaap |
Assets
Assets
|
8954000000 | USD |
| CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5988000000 | USD |
| CY2017Q3 | us-gaap |
Assets Current
AssetsCurrent
|
7708000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
1761000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
2115000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
1758000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
2113000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
3000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
0 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
4000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
2000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
841000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
880000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
0 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
58000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
17000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
17000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
944000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
943000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
|
2113000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
1154000000 | USD |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
1153000000 | USD |
| CY2016Q4 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
580 | Security |
| CY2017Q3 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
430 | Security |
| CY2016Q4 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
0 | Security |
| CY2017Q3 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
20 | Security |
| CY2016Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
1000000 | USD |
| CY2017Q3 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
1000000 | USD |
| CY2016Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
198000000 | USD |
| CY2017Q3 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
198000000 | USD |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2329000000 | USD |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2842000000 | USD |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2819000000 | USD |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3934000000 | USD |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
513000000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1115000000 | USD | |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
53.8475 | |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
57000000 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
57000000 | shares |
| CY2016Q4 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
0 | USD |
| CY2017Q3 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
0 | USD |
| CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
41000000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
106000000 | USD | |
| CY2017Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-97000000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-249000000 | USD | |
| CY2016Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
4428000000 | USD |
| us-gaap |
Costs And Expenses
CostsAndExpenses
|
12936000000 | USD | |
| CY2017Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
5112000000 | USD |
| us-gaap |
Costs And Expenses
CostsAndExpenses
|
15220000000 | USD | |
| CY2016Q4 | us-gaap |
Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
|
86000000 | USD |
| CY2017Q3 | us-gaap |
Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
|
97000000 | USD |
| CY2013 | us-gaap |
Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
|
13490236 | shares |
| CY2016Q4 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
6000000 | USD |
| CY2017Q3 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
6000000 | USD |
| CY2016Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
11000000 | USD |
| CY2017Q3 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
13000000 | USD |
| CY2016Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
10000000 | USD |
| CY2017Q3 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
62000000 | USD |
| CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
315000000 | USD |
| CY2017Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
468000000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
15000000 | USD |
| CY2017Q3 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
0 | USD |
| CY2016Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
36000000 | USD |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
102000000 | USD | |
| CY2017Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
33000000 | USD |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
109000000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
135000000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
139000000 | USD | |
| CY2016Q4 | us-gaap |
Derivative Assets Current
DerivativeAssetsCurrent
|
267000000 | USD |
| CY2017Q3 | us-gaap |
Derivative Assets Current
DerivativeAssetsCurrent
|
425000000 | USD |
| us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD | |
| us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD | |
| CY2016Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
267000000 | USD |
| CY2017Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
425000000 | USD |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.77 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.79 | ||
| CY2017Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.70 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.44 | ||
| CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.76 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.77 | ||
| CY2017Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.70 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.44 | ||
| CY2017Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
27000000 | USD |
| us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
186000000 | USD | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
140000000 | USD |
| CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
101000000 | USD |
| CY2016Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
343000000 | USD |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1034000000 | USD | |
| CY2017Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
383000000 | USD |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1227000000 | USD | |
| CY2016Q4 | us-gaap |
Goodwill
Goodwill
|
620000000 | USD |
| CY2017Q3 | us-gaap |
Goodwill
Goodwill
|
430000000 | USD |
| CY2016Q3 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
0 | USD |
| us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
0 | USD | |
| CY2017Q3 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
129000000 | USD |
| us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
201000000 | USD | |
| CY2016Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
678000000 | USD |
| CY2016Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
58000000 | USD |
| CY2017Q3 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
248000000 | USD |
| CY2016 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | USD |
| CY2017Q2 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
61000000 | USD |
| CY2017Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
129000000 | USD |
| CY2016Q3 | us-gaap |
Gross Profit
GrossProfit
|
457000000 | USD |
| us-gaap |
Gross Profit
GrossProfit
|
1331000000 | USD | |
| CY2017Q3 | us-gaap |
Gross Profit
GrossProfit
|
564000000 | USD |
| us-gaap |
Gross Profit
GrossProfit
|
1364000000 | USD | |
| CY2016Q3 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
4191000000 | USD |
| us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
12215000000 | USD | |
| CY2017Q3 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
4777000000 | USD |
| us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
14165000000 | USD | |
| CY2017Q3 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
117000000 | USD |
| CY2017Q3 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
17000000 | USD |
| CY2017Q3 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
17000000 | USD |
| CY2017Q3 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
100000000 | USD |
| CY2017Q3 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
100000000 | USD |
| CY2017Q3 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
117000000 | USD |
| CY2016 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | USD |
| CY2017Q2 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
11000000 | USD |
| CY2016Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
92000000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
236000000 | USD | |
| CY2017Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-113000000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-296000000 | USD | |
| CY2016Q3 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
| us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD | |
| CY2017Q3 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
| us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD | |
| CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
50000000 | USD |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
137000000 | USD | |
| CY2017Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-16000000 | USD |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-46000000 | USD | |
| CY2016Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
39000000 | USD |
| CY2017Q3 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
60000000 | USD |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1000000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
90000000 | USD | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
32000000 | USD | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-22000000 | USD | |
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-20000000 | USD | |
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
68000000 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
157000000 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
153000000 | USD | |
| us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
168000000 | USD | |
| us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
549000000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
116000000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
53000000 | USD | |
| us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
427000000 | USD | |
| us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
28000000 | USD | |
| us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
-4000000 | USD | |
| us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
10000000 | USD | |
| CY2016Q3 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
| us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
1000000 | shares | |
| CY2017Q3 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
| us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares | |
| CY2016Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
760000000 | USD |
| CY2017Q3 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
531000000 | USD |
| CY2016Q3 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
10000000 | USD |
| us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
29000000 | USD | |
| CY2017Q3 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
18000000 | USD |
| us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
48000000 | USD | |
| CY2016Q3 | us-gaap |
Interest Expense
InterestExpense
|
26000000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
76000000 | USD | |
| CY2017Q3 | us-gaap |
Interest Expense
InterestExpense
|
32000000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
85000000 | USD | |
| CY2016Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
0 | USD |
| CY2017Q3 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
0 | USD |
| CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
5800000000 | USD |
| CY2017Q3 | us-gaap |
Liabilities
Liabilities
|
7525000000 | USD |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7449000000 | USD |
| CY2017Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8954000000 | USD |
| us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
28000000 | USD | |
| us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD | |
| CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4570000000 | USD |
| CY2017Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5962000000 | USD |
| CY2015Q4 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
1685000000 | USD |
| CY2017Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1787000000 | USD |
| CY2016Q3 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
1871000000 | USD |
| CY2016Q4 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
1929000000 | USD |
| CY2017Q3 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
2478000000 | USD |
| us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
|
9536000000 | USD | |
| us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
|
10944000000 | USD | |
| us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
|
1278000000 | USD | |
| us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
|
1501000000 | USD | |
| CY2016Q4 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
|
1352000000 | USD |
| CY2017Q3 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
|
1681000000 | USD |
| us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
|
10930000000 | USD | |
| us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
|
12822000000 | USD | |
| CY2016Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
1173000000 | USD |
| CY2017Q3 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
1515000000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
472000000 | USD |
| CY2017Q3 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
782000000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
|
1645000000 | USD |
| CY2017Q3 | us-gaap |
Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
|
2297000000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
975000000 | USD |
| CY2017Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1317000000 | USD |
| CY2016Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1758000000 | USD |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
632000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-131000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-474000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
633000000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
957000000 | USD | |
| CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
42000000 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
99000000 | USD | |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-97000000 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-250000000 | USD | |
| CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-26000000 | USD |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-76000000 | USD | |
| CY2017Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-32000000 | USD |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-10000000 | USD | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | Segment | |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
118000000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
312000000 | USD | |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-81000000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-286000000 | USD | |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
41000000 | USD |
| CY2017Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
42000000 | USD |
| CY2016Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1000000 | USD |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
7000000 | USD | |
| CY2017Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
3000000 | USD | |
| CY2017Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
1000000 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
1000000 | USD | |
| CY2016Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
42000000 | USD |
| CY2017Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
48000000 | USD |
| CY2016Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD | |
| CY2017Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
75000000 | USD | |
| us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
14000000 | USD | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
1000000 | USD | |
| CY2016Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-3000000 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
10000000 | USD | |
| CY2017Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
1000000 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
2000000 | USD | |
| CY2016Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-2000000 | USD |
| us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
13000000 | USD | |
| us-gaap |
Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
|
10814000000 | USD | |
| us-gaap |
Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
|
12445000000 | USD | |
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
12000000 | USD | |
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
21000000 | USD | |
| us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
24000000 | USD | |
| us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD | |
| us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
48000000 | USD | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
1444000000 | USD | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
1896000000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
143000000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
85000000 | USD | |
| CY2016Q3 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
3748000000 | USD |
| us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
10930000000 | USD | |
| CY2017Q3 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
4220000000 | USD |
| us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
12822000000 | USD | |
| CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
| CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2017Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
131000000 | USD |
| CY2017Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
174000000 | USD |
| us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
325000000 | USD | |
| us-gaap |
Proceeds From Dividends Received
ProceedsFromDividendsReceived
|
0 | USD | |
| us-gaap |
Proceeds From Dividends Received
ProceedsFromDividendsReceived
|
0 | USD | |
| us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
0 | USD | |
| us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
325000000 | USD | |
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
10000000 | USD | |
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
11000000 | USD | |
| us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
0 | USD | |
| us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
300000000 | USD | |
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
1000000 | USD | |
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-4000000 | USD | |
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
1512000000 | USD | |
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
1538000000 | USD | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
454000000 | USD |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
397000000 | USD |
| CY2016Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
974000000 | USD |
| CY2017Q3 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
1002000000 | USD |
| CY2016Q3 | us-gaap |
Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
|
72000000 | USD |
| CY2017Q3 | us-gaap |
Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
|
16000000 | USD |
| CY2016Q4 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
0 | USD |
| CY2017Q3 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
0 | USD |
| CY2016Q4 | us-gaap |
Restricted Investments Current
RestrictedInvestmentsCurrent
|
0 | USD |
| CY2017Q3 | us-gaap |
Restricted Investments Current
RestrictedInvestmentsCurrent
|
326000000 | USD |
| CY2016Q4 | us-gaap |
Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
|
110000000 | USD |
| CY2017Q3 | us-gaap |
Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
|
117000000 | USD |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
89000000 | USD | |
| CY2016Q3 | us-gaap |
Restructuring Costs
RestructuringCosts
|
0 | USD |
| us-gaap |
Restructuring Costs
RestructuringCosts
|
0 | USD | |
| CY2017Q3 | us-gaap |
Restructuring Costs
RestructuringCosts
|
118000000 | USD |
| us-gaap |
Restructuring Costs
RestructuringCosts
|
161000000 | USD | |
| CY2016Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
0 | USD |
| CY2017Q3 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
65000000 | USD |
| CY2017Q3 | us-gaap |
Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
|
50000000 | USD |
| CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
810000000 | USD |
| CY2017Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
560000000 | USD |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
4546000000 | USD |
| us-gaap |
Revenues
Revenues
|
13248000000 | USD | |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
5031000000 | USD |
| us-gaap |
Revenues
Revenues
|
14934000000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
24000000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
38000000 | USD | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
69346 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
54.37 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
617373 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
57.16 | ||
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
922900 | shares |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
679081 | shares |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
58.15 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
57.61 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
791846 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
57.78 | ||
| CY2017Q3 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
|
1828000000 | USD |
| CY2017Q3 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
|
1113000000 | USD |
| us-gaap |
Stock Issued1
StockIssued1
|
8000000 | USD | |
| us-gaap |
Stock Issued1
StockIssued1
|
21000000 | USD | |
| us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
29000000 | USD | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1649000000 | USD |
| CY2017Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1429000000 | USD |
| us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
-220000000 | USD | |
| us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
|
11120000000 | USD | |
| us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
|
12813000000 | USD | |
| us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
|
-190000000 | USD | |
| us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
|
9000000 | USD | |
| CY2016Q3 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
119000000 | USD |
| us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
362000000 | USD | |
| CY2017Q3 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
123000000 | USD |
| us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
369000000 | USD | |
| CY2016Q3 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
133000000 | USD |
| us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
408000000 | USD | |
| CY2017Q3 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
130000000 | USD |
| us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
390000000 | USD | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
56000000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
56000000 | shares | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
57000000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
56000000 | shares | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
56000000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
55000000 | shares | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
57000000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
56000000 | shares | |
| us-gaap |
Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated:</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">December 31,<br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">125</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">615</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,929</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> |
